CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Metatissue develops human-derived proteins to create hydrogels and bioinks for enhanced 3D cell culture and disease modeling. This technology supports drug discovery, tissue engineering, and personalized medicine by providing a human-based environment for cell growth and function control.
Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks to improve 3D cell culture and disease modelling for drug discovery and development, tissue engineering, and personalized medicine advancements.Metatissue has developed a bioactive platelet-rich plasma derivative precursor that can be cured upon light exposure to form soft materials with tunable mechanical properties.
Such materials provide…
METATISSUE - BIOSOLUTIONS, LDA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
